Asbestos Lung Mesothelioma and cancer Metastasis Treatment And More

Rosetta Genomics announced the publication of a study of MicroRNA Expression lung tumor classification of Rosetta Genomics, Ltd. (NASDAQ: ROSG), the developer and provider of microRNA-based molecular diagnostic tests, announced the publication of a study showing the difference between the expression microRNA primary lung tumors and metastases to the lungs. The study, entitled "MicroRNA Expression [...]